PP
LEGN icon

Prudential plc’s Legend Biotech LEGN Stock Holding History

Prudential plc’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,420
Closed -$297K – 715
2026
Q1 		$297K Sell
16,420
-304
-2% -$5.79K ﹤0.01% 644
2025
Q4 		$364K Sell
16,724
-16,238
-49% -$465K ﹤0.01% 642
2025
Q3 		$1.07M Sell
32,962
-3,997
-11% -$148K 0.01% 465
2025
Q2 		$1.31M Hold
36,959
– – 0.01% 462
2025
Q1 		$1.25M Sell
36,959
-2,607
-7% -$93.5K 0.01% 459
2024
Q4 		$1.29M Buy
39,566
+12,744
+48% +$528K 0.01% 468
2024
Q3 		$1.31M Buy
26,822
+4,566
+21% +$243K 0.01% 470
2024
Q2 		$986K Buy
22,256
+3,498
+19% +$161K 0.01% 480
2024
Q1 		$1.05M Buy
18,758
+3,902
+26% +$235K 0.01% 491
2023
Q4 		$894K Buy
14,856
+5,949
+67% +$377K 0.01% 615
2023
Q3 		$598K Buy
8,907
+544
+7% +$37.8K 0.01% 697
2023
Q2 		$577K Buy
8,363
+3,099
+59% +$202K 0.01% 741
2023
Q1 		$254K Hold
5,264
– – ﹤0.01% 842
2022
Q4 		$263K Buy
+5,264
New +$255K ﹤0.01% 843

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Prudential plc's LEGN Position: Q2 2026 in Review

Prudential plc sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 16,420 shares — an estimated $297K sold.

Prudential plc first reported a position in LEGN in Q4 2022 and held it in 14 quarters. The position peaked at $1.31M in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Prudential plc reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Prudential plc sold 16,420 Legend Biotech shares in Q2 2026, an estimated $297K.
  • Prudential plc first reported a position in Legend Biotech in Q4 2022 and held it in 14 quarters.
  • Prudential plc's Legend Biotech position peaked at $1.31M in Q2 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.